Azacitidine Celgene Європейський Союз - польська - EMA (European Medicines Agency)

azacitidine celgene

celgene europe bv - azacytydyna - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Środki przeciwnowotworowe - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

Azacitidine Mylan Європейський Союз - польська - EMA (European Medicines Agency)

azacitidine mylan

mylan ireland limited - azacytydyna - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Środki przeciwnowotworowe - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Desloratadine Teva Європейський Союз - польська - EMA (European Medicines Agency)

desloratadine teva

teva b.v - desloratadyna - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - leki przeciwhistaminowe do stosowania systemowego, - Дезлоратадин teva jest wskazany do łagodzenia objawów związanych z:alergicznym zapaleniem błony śluzowej nosa;pokrzywka.